Asia & Pacific Legal Chronicle. October 6, 2021

Cellomics’ Series B financing

By Martina Bellini

Sidley Austin advised Cellomics on the deal. Cellomics, a leading Hong Kong-based biotech company focusing on development and commercialization of liquid biopsy products for cancer screening...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here